Splenomegaly

19 registered clinical trials studyying Splenomegaly — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Study of the Prevalence of Acid Sphingomyelinase Deficiency/Niemann Pick AB and B Disease in Patients With Dif NCT06869499	Wladimir MAUHIN, Dr	N/A
Recruiting	High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly NCT06345495	M.D. Anderson Cancer Center	Phase 2
Completed	PREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD" NCT05641103	Fundación Española de Hematología y Hemoterapía	—
Completed	Incentive Spirometry and Upper Abdominal Laparoscopic Surgery NCT04716166	Riphah International University	N/A
Recruiting	Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders NCT03801434	William Shomali	Phase 2
Withdrawn	Biomarker for Farber Disease (BioFarber) NCT02298634	CENTOGENE GmbH Rostock	—
Withdrawn	Biomarker for Gaucher Disease: BioGaucher (BioGaucher) NCT01331642	CENTOGENE GmbH Rostock	—
Withdrawn	Biomarker for Sly Disease (MPS VII) (BioSly) NCT02298699	CENTOGENE GmbH Rostock	—
Completed	Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chr NCT02948283	City of Hope Medical Center	Phase 1
Terminated	Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia NCT02730884	M.D. Anderson Cancer Center	Phase 2
Completed	Obinutuzumab and Lenalidomide in Treating Patients With Previously Untreated Stage II-IV Grade 1-3a Follicular NCT02871219	M.D. Anderson Cancer Center	Phase 2
Terminated	The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Depart NCT02463669	Jewish General Hospital	—
Completed	A National Study in Patients With Unexplained Splenomegaly NCT04430881	Sanofi	—
Terminated	Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Po NCT02421354	M.D. Anderson Cancer Center	Phase 2
Completed	Estimation of Spleen by Residents With VScan NCT01907932	University of British Columbia	N/A
Completed	Ultrasound Estimation of Spleen Size NCT01810419	University of British Columbia	N/A
Completed	Evaluation of a Pocket-Sized Ultrasound Device As an Aid to the Physical Examination NCT01948076	Brigham and Women's Hospital	N/A
Unknown	Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Ci NCT01201655	Xijing Hospital	—
Completed	Spleen Size in Peripheral Blood Stem Cell Donors NCT00006148	National Institutes of Health Clinical Center (CC)	—